HEMORIO - Unidade de Pesquisa Clínica
Rio De Janeiro, Brazil
Blood bank in Rio de Janeiro, State of Rio de Janeiro
R. Frei Caneca, 8 - Centro, Rio de Janeiro - RJ, 20211-030
About HEMORIO - Unidade de Pesquisa Clínica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at HEMORIO - Unidade de Pesquisa Clínica
During the past decade, HEMORIO - Unidade de Pesquisa Clínica conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
2003-08-01
2016-12-01
Completed
1,706
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
2004-05-01
2016-05-01
Completed
2,722
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
2006-08-01
2016-02-01
Completed
1,038
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
2006-02-01
2011-03-01
Terminated
208
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at HEMORIO - Unidade de Pesquisa Clínica
According to Clinical.Site data, the most researched conditions in "HEMORIO - Unidade de Pesquisa Clínica" are
"Sickle Cell Disease" (2 trials), "Vaso-occlusive Crisis" (2 trials), "Vaso-occlusive Pain Episode in Sickle Cell Disease" (2 trials), "Isocitrate Dehydrogenase" (1 trials) and "Leukemia, Myeloid" (1 trials). Many other conditions were trialed in "HEMORIO - Unidade de Pesquisa Clínica" in a lesser frequency.
Clinical Trials Intervention Types at HEMORIO - Unidade de Pesquisa Clínica
Most popular intervention types in "HEMORIO - Unidade de Pesquisa Clínica" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Inclacumab" (2 trials), "AG-221" (1 trials), "Azacitidine" (1 trials) and "BSC" (1 trials). Other intervention names were less common.
Clinical Trials Genders at HEMORIO - Unidade de Pesquisa Clínica
The vast majority of trials in "HEMORIO - Unidade de Pesquisa Clínica" are
4 trials for "All" genders.
Clinical Trials Status at HEMORIO - Unidade de Pesquisa Clínica
Currently, there are NaN active trials in "HEMORIO - Unidade de Pesquisa Clínica".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in HEMORIO - Unidade de Pesquisa Clínica,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in HEMORIO - Unidade de Pesquisa Clínica, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".